CERRITOS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, is pleased to announce a new partnership with Protocol Behavioral Health, a leading provider of evidence-based mental health care for cancer patients. This collaboration underscores TOI’s commitment to delivering whole-person care by integrating behavioral health services directly into the cancer care journey.
Research shows that approximately 30% of cancer patients experience significant depression or anxiety, and oncologists widely agree that behavioral health support can benefit nearly every patient. Through this partnership, TOI patients will gain timely access to mental health services that are tailored specifically to the emotional and psychological challenges of cancer, with no waitlists and full integration into the patient’s care team, and the added benefit of services offered in multiple languages to support our diverse patient population.
“Anxiety and depression can greatly threaten a patient’s outcome by affecting their ability to complete treatment in the recommended time,” said Yale Podnos, MD, Chief Medical Officer at The Oncology Institute. “By embedding behavioral health services directly into our care model, we’re closing a critical gap in oncology and ensuring our patients have access to the support they need, exactly when they need it.”
Key Benefits of the Partnership:
“We founded Protocol to meet a clear need in oncology,” said Cara Bohon, PhD, Chief Clinical Officer of Protocol Behavioral Health. “Through this partnership, we’re ensuring that mental health care is not a luxury or an afterthought; it’s a core part of the patient’s treatment plan from day one.”
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
About Protocol Behavioral Health (www.protocolcares.com):
Protocol Behavioral Health provides timely, evidence-based mental health care tailored to the unique needs of cancer patients. Using the Collaborative Care Model, Protocol integrates behavioral health managers and psychiatric providers directly into oncology care teams. This model ensures seamless coordination, personalized support, and better outcomes for patients experiencing depression, anxiety, and other behavioral health challenges.
Media
The Oncology Institute, Inc.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investors
ICR Healthcare
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$3.88 |
| Daily Change: | 0.11 2.92 |
| Daily Volume: | 4,408,118 |
| Market Cap: | US$381.710M |
November 13, 2025 November 13, 2025 September 02, 2025 August 18, 2025 August 13, 2025 | |

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load